CompoAtlas

Fusan Herbs Enermen Capsule

Fusan Herbs Enermen Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Tribulus terrestrisTribulus terrestris[90.00 mg,260.00 mg]Not identified
Epimedium sagittatumEpimedium sagittatum[70.00 mg,260.00 mg]Not identified
Eurycoma longifoliaEurycoma longifolia[50.00 mg,260.00 mg]Not identified
Lepidium meyeniiLepidium meyenii[50.00 mg,260.00 mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL18096049T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
SYARIKAT WEN KEN DRUG SDN. BHD.
Manufacturer
SYARIKAT WEN KEN DRUG SDN. BHD.
Registration period starting
2023-09-06
Published validity end
2028-09-06

Original register data

View published fields and their variants
Active ingredients
Tribulus terrestris[90.00 mg,260.00 mg],Epimedium sagittatum[70.00 mg,260.00 mg],Eurycoma longifolia[50.00 mg,260.00 mg],Lepidium meyenii[50.00 mg,260.00 mg]
Valid until
2028-09-06
Registration date
2023-09-06
Published description
NATURAL PRODUCT
Licence holder
SYARIKAT WEN KEN DRUG SDN. BHD.
Producer
SYARIKAT WEN KEN DRUG SDN. BHD.
Published name
Fusan Herbs Enermen Capsule
Published reference
201805180473T
Registration number
MAL18096049T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL18096049T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Tribulus terrestris
    Read the warning, when it applies and the studies cited

    TRIBULUS - TRIBULUS TERRESTRIS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except Vrsya (aphrodisiac for men).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Chen and Chen 2004).

    Sources cited by Health Canada (1)
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.

    Condition of application: Traditional Chinese Medicine.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have qi or blood deficiency (Bensky et al. 2004).

    Sources cited by Health Canada (1)
    • Bensky D, Clavey S, Toger E, Gamble A, editors. Chinese Herbal Medicine Materia Medica. 3rd edition. Seattle (WA): Eastland Press Inc; 2004.

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have low blood pressure or liver deficiency (Bensky et al. 2004; Chen and Chen 2004).

    Sources cited by Health Canada (2)
    • Bensky D, Clavey S, Toger E, Gamble A, editors. Chinese Herbal Medicine Materia Medica. 3rd edition. Seattle (WA): Eastland Press Inc; 2004.
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (Bensky et al. 2004)

    Sources cited by Health Canada (1)
    • Bensky D, Clavey S, Toger E, Gamble A, editors. Chinese Herbal Medicine Materia Medica. 3rd edition. Seattle (WA): Eastland Press Inc; 2004.

    Condition of application: All products except Mutrala (diuretic).

    When using this product diuretic effect may occur.

    Health Canada monograph dated 29 May 2026

  • Lepidium meyenii
    Read the warning, when it applies and the studies cited

    Maca - Lepidium Meyenii

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Applies to products providing 0.6 g or more dried root/hypocotyl, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a blood pressure condition (Valentova et al. 2008).

    Sources cited by Health Canada (1)
    • Valentova K, Stejskal D, Bartek J, Dvoráckova S, Kren V, Ulrichova J, Simanek V. Maca (Lepidium meyenii) and yacon (Smallanthus sonchifolius) in combination with silymarin as food supplements: in vivo safety assessment. Food and Chemical Toxicology 2008;46(3):1006-1013. PubMed Randomised trial

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).

    Sources cited by Health Canada (2)
    • Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomised trial
    • Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed

    Condition of application: Healthy mood balance; Sexual health.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression (Brotto 2010; Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).

    Sources cited by Health Canada (3)
    • Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Archives of Sexual Behavior 2010;39(2):221-239. PubMed Review article
    • Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomised trial
    • Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed

    Health Canada monograph dated 27 September 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Fusan Herbs Enermen Capsule”, https://compoatlas.com/en/supplements/malaysia/MAL18096049T-fusan-herbs-enermen-capsule, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line